Pharmaceutical intervention in the prevention of adverse events as a quality indicator of hospital assistance
DOI:
https://doi.org/10.47456/rbps.v22i3.21496Keywords:
Rational Drug Utilization, Quality Indicators, Pharmaceutical ServiceAbstract
Introduction: Clinical Pharmacy is part of the pharmaceutical care, and covers all areas of health care and it was within the hospital scope that the Pharmacy Clinic began, among the various activities performed by the clinical pharmacist, the pharmaceutical intervention is the main one. Objective: To analyze the interventions performed by clinical pharmacists during the medical prescriptions’ review in the surgical clinics, from a SUS Hospital in the city of Sobral, Ceará, in the year 2016. Methods: A retrospective, observational, exploratory and documentary study was performed through reports issued annually by this service in a database of data on the activities of the Clinical Pharmacy. Results: There were identified 1512 problems related to the drug being those of greater incidence those related to the necessity parameter. The number of interventions performed (1512) was equal to the quantity of problems related with the encountered drug, but only 464 (34%) had acceptance, 1048 (66%) were not accepted, being a majority for reasons not justified. The most taken measure in relation to the interventions accepted was the alteration in the prescription, with doctors being the most sought after by the clinical pharmacist. Conclusion: The pharmaceutical interventions allowed to identify several problems related to the drug, thus avoiding adverse events, because when accepted by the professionals contacted, corrective measures were taken, providing therapeutic success.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Revista Brasileira de Pesquisa em Saúde/Brazilian Journal of Health Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Revista Brasileira de Pesquisa em Saúde (RBPS) adopts the CC BY 4.0 license, which means that authors retain the copyright of the works they submit to the journal. Authors are responsible for declaring that their contribution is an original manuscript, that it has not been previously published, and that it is not under simultaneous review by another scientific journal. Upon submitting the manuscript, authors grant RBPS the exclusive right of first publication, subject to peer review.
Authors are permitted to enter into additional contracts for the non-exclusive distribution of the version published by RBPS (for example, in institutional repositories or as a book chapter), provided that due acknowledgment of authorship and of initial publication by RBPS is given. Authors are also encouraged to make their work available online (for example, in institutional repositories or on their personal pages) after its initial publication in the journal, with due acknowledgment of authorship and of the original publication by RBPS.
Accordingly, under the CC BY 4.0 license, readers have the right to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially;
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
